41 records – page 1 of 3.

Amendments to PIPEDA, Bill S-4

https://policybase.cma.ca/link/policy11194
Date
2014-06-09
Topics
Health information and e-health
Ethics and medical professionalism

Appearance before the House of Commons Standing Committee on Health

https://policybase.cma.ca/link/policy14475
Date
2022-05-09
Topics
Health systems, system funding and performance
Ethics and medical professionalism

Appearance before the Standing Committee on Indigenous and Northern Affairs (INAN): Administration and accessibility of Indigenous Peoples to the Non-Insured Benefits Program

https://policybase.cma.ca/link/policy14474
Date
2022-05-03
Topics
Population health, health equity, public health
Ethics and medical professionalism

Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)

https://policybase.cma.ca/link/policy11297
Date
2014-10-28
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)

https://policybase.cma.ca/link/policy11519
Date
2015-05-14
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Bill C-17 An Act to amend the Food and Drugs Act

https://policybase.cma.ca/link/policy11196
Date
2014-06-11
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Bill C-45: The Cannabis Act

https://policybase.cma.ca/link/policy13723
Date
2017-08-18
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Bill C-45: The Cannabis Act

https://policybase.cma.ca/link/policy13861
Date
2018-04-18
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Canada’s doctors and nurses urgently calling for federal measures to address Canada’s health workforce crisis

https://policybase.cma.ca/link/policy14460
Date
2021-11-09
Topics
Ethics and medical professionalism
Policy Type
Parliamentary submission
Date
2021-11-09
Topics
Ethics and medical professionalism
Documents
Less detail

Canadian Medical Association input in advance of the World Health Assembly Special Session

https://policybase.cma.ca/link/policy14461
Date
2021-11-17
Topics
Population health, health equity, public health
Ethics and medical professionalism

Canadian Medical Association submission to the Standing Senate Committee on Banking, Trade and Commerce: Higher rate now: Why excise tax on tobacco is long overdue for an increase

https://policybase.cma.ca/link/policy11129
Date
2014-05-15
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

CMA Presentation to the Senate Standing Committee on Social Affairs, Science and Technology - Prescription Drugs: Clinical Trials and Approval

https://policybase.cma.ca/link/policy10437
Date
2012-05-09
Topics
Pharmaceuticals, prescribing, cannabis, drugs

CMA Recommendations on Vaccine Equity and Intellectual Property

https://policybase.cma.ca/link/policy14476
Date
2022-05-13
Topics
Ethics and medical professionalism
Pharmaceuticals, prescribing, cannabis, drugs
Population health, health equity, public health

CMA Response: Health Canada's Medical Marijuana Regulatory Proposal

https://policybase.cma.ca/link/policy10702
Date
2013-02-28
Topics
Pharmaceuticals, prescribing, cannabis, drugs

CMA’s formal submission to the Federal External Panel on assisted dying

https://policybase.cma.ca/link/policy11750
Last Reviewed
2019-03-03
Date
2015-10-19
Topics
Ethics and medical professionalism
Policy Type
Parliamentary submission
Last Reviewed
2019-03-03
Date
2015-10-19
Topics
Ethics and medical professionalism
Documents
Less detail

CMA’s Recommendations for Bill S-5: An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts

https://policybase.cma.ca/link/policy13641
Date
2017-04-07
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

CMA’s Recommendations for Bill S-5 An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts

https://policybase.cma.ca/link/policy13918
Date
2018-02-15
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Health care and patient safety

CMA's Submission to the House of Commons Standing Committee on Health: Drug Shortages

https://policybase.cma.ca/link/policy10382
Date
2012-03-29
Topics
Pharmaceuticals, prescribing, cannabis, drugs

CMA's Submission to the Senate Committee on Social Affairs, Science and Technology as part of its study on prescription pharmaceuticals: Federal levers to address unintended consequences of prescription pharmaceuticals and support public health, quality care, and patient safety

https://policybase.cma.ca/link/policy11125
Date
2014-03-26
Topics
Pharmaceuticals, prescribing, cannabis, drugs

CMA's Submission to the Senate Committee on Social Affairs, Science and Technology - Prescription Pharmaceuticals in Canada: The Post-Approval Monitoring of Prescription Pharmaceuticals

https://policybase.cma.ca/link/policy10631
Date
2012-10-24
Topics
Pharmaceuticals, prescribing, cannabis, drugs

41 records – page 1 of 3.